Lymphoma & Myeloma

Lymphoma & Myeloma are hematologic cancers that affect the lymphatic system and plasma cells, respectively. Lymphoma involves abnormal growth of lymphocytes, leading to Hodgkin’s and non-Hodgkin’s subtypes, while Multiple Myeloma is a cancer of plasma cells in the bone marrow. Research and treatment focus on early diagnosis, targeted therapies, immunotherapy, stem cell transplantation, and strategies to improve patient survival and quality of life.

• Lymphoma is a cancer of the lymphatic system, involving abnormal growth of lymphocytes.
• It includes Hodgkin’s lymphoma and non-Hodgkin’s lymphoma subtypes.
• Multiple Myeloma is a cancer of plasma cells in the bone marrow.
• Both conditions can affect immunity and blood cell production.
• Diagnosis involves blood tests, imaging, and biopsy of lymph nodes or bone marrow.
• Treatment options include chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation.
• Research focuses on improving survival, reducing side effects, and developing personalized therapies.